Eli Lilly says its experimental drug retatrutide produced near‑surgical levels of weight loss in late‑stage trials, but analysts note higher side effects and access questions.

A new Crossroads Academic Medical Institute launched in Indianapolis to coordinate clinical training across the state and widen access to care. Universities and hospital systems will share sites and curricula.

Sam Schmidt converted the old Five Seasons club into a 114,000‑sq‑ft DRIVEN Neuro Recovery Center in Carmel, pairing deep‑water therapy, robotic gait trainers and nonprofit care. The campus aims to offer long‑term rehab beyond typical insurance limits.

Mounjaro's Q1 sales topped Keytruda, lifting Lilly's revenue and reshaping the blockbuster drug ranking.

Gov. Mike Braun and business leaders launched IN AI, a statewide hub and roadshows to help Hoosier employers use human-centered AI to increase productivity and wages.

Eli Lilly agreed to buy Ajax Therapeutics for up to $2.3 billion, taking on a Cambridge biotech's experimental Type II JAK2 drug for myelofibrosis with data due in 2026.

Carmel will pilot Qwake’s C‑THRU AR helmets this summer — 16 helmets and four command tablets in a three‑year, $375K program funded with help from the Heroes Club.

Eli Lilly is reportedly in advanced talks to buy Boston‑based Kelonia Therapeutics for more than $2 billion, folding a promising in‑vivo CAR‑T program into Lilly’s pipeline.

Franciscan Alliance is moving to build an osteopathic medical school in Crown Point, with leadership roles posted and campus work already under way.

A federal appeals court revived Teva’s patent fight with Eli Lilly and sent the case back to Massachusetts, reopening a dispute that once produced a $176.5M jury award.

Indiana University physicians were co‑authors on a NEJM trial showing enfortumab vedotin plus pembrolizumab produced large survival gains for certain bladder cancer patients. IU sites helped enroll and analyze the data behind the finding.

Gov. Mike Braun toured Ossium Health’s Indianapolis bone‑marrow bank as the state spotlights a $1 billion life‑sciences growth plan.

Eric Christopher, the co-founder of Zylo, will take over as TechPoint’s president and CEO on April 7, stepping into a statewide role focused on talent, capital and AI. The hire follows a national search and the departure of Ting Gootee to CICP.